* onbrez breezhaler (Indacaterol) 150 mcg Inhalation Powder hard capsule 30 capsules and 1 inhaler. (long-acting beta2 agonist used as bronchodilator in maintenance treatment of COPD).

* Each capsule contains: 150 micrograms indacaterol, Equivalent to 194 micrograms of indacaterol maleate. Excipients: Lactose monohydrate, gelatin..

* Therapeutic indications: Onbrez Breezhaler is indicated for maintenance bronchodilator treatment of airflow obstruction in adult patients with chronic obstructive pulmonary disease (COPD).

* Pharmacotherapeutic group: Drugs for obstructive airways diseases, selective beta-2-adrenoreceptor agonists, ATC code: R03AC18

* Onbrez capsules must be administered only by the oral inhalation route and only using the Breezhaler inhaler.

* Onbrez capsules must not be swallowed.

* Do not store above 30 degrees C. Store in the original package in order to protect from moisture.

* Onbrez capsules must always be stored in the blister, and only removed immediately before use.

* Discard the Breezhaler device 1 month after first use.

* Medicinal product subject to medical prescription.

* Manufactured by: NOVARTIS Pharma Stein AG, Stein – Switzerland. For: Novartis Pharma AG, Basle – Switzerland. استيراد الشركة المصرية السويسرية لصالح نوفارتس